OTC Product Roundup: Allergies

By addressing integration barriers associated with implementing tobacco cessation programs in the community pharmacy, community pharmacists can “significantly impact public health by increasing access to effective cessation support,” wrote investigators.

A study from the Children’s Hospital of Philadelphia found that a positive PCR test was not associated with an increased risk of a new asthma diagnosis in patients ages 1 to 16.

Test your pharmacy news knowledge with our weekly quiz.

Fasenra was initially approved in 2017 as an add on maintenance therapy in patients aged 12 years and older.

Abrysvo is currently approved to treat RSV-associated lower respiratory tract disease in adults aged 60 years and older, and in infants through the immunization of pregnant individuals.

The drug had previously been granted a breakthrough therapy designation by the FDA.